Enumeral Biomedical Holdings, Inc.
company.status.inactiveCIK 1561551fmd_1GYE1NY57K6E4KATRS9M8CSPD4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2012 to Sep 30, 2017, 24 periods
| Line item | FY2013 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 1 | – |
| Net interest income | – | – | – | 0 | (5) |
| Research and development | – | 2 | 4 | 6 | 5 |
| Total operating expenses | – | 4 | 7 | 12 | 9 |
| Operating income | – | (4) | (6) | (11) | (7) |
| Interest expense | – | 0 | 0 | (0) | 4 |
| Other non-operating income (expense) | – | (0) | (2) | 14 | (5) |
| Income before taxes | – | (4) | (8) | 3 | (12) |
| Income tax expense | – | 0 | 0 | – | – |
| Net income from continuing operations | – | (4) | (8) | – | – |
| Net income | (0) | – | (8) | 3 | (12) |